Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rutgers

Showing results (151-160 of 179) with videos related to

Pageof 18
Sort By:
British Journal of Cancer|April 1, 1995
High-dose carboplatin, thiotepa and cyclophosphamide (CTC) with peripheral blood stem cell support in the adjuvant therapy of high-risk breast cancer: a practical approachE van der Wall, W J Nooijen, J W Baars, et al.
International Journal of Radiation Oncology, Biology, Physics|September 17, 2019
Response to Preoperative Radiation Therapy in Relation to Gene Expression Patterns in Breast Cancer PatientsSophie C J Bosma, Marlous Hoogstraat, Femke van der Leij, et al.
European Journal of Cancer (Oxford, England : 1990)|February 16, 2000
Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer. Dutch Study Group on local Recurrence after Breast Conservation (BORST)A C Voogd, J L Peterse, M A Crommelin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2018
Clinicopathological Risk Factors for an Invasive Breast Cancer Recurrence after Ductal Carcinoma <i>In Situ</i>-A Nested Case-Control StudyLindy L Visser, Lotte E Elshof, Michael Schaapveld, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|March 12, 2013
First clinical experience with a dedicated PET for hanging breast molecular imagingB B Koolen, T S Aukema, A J González Martínez, et al.
International Journal of Cancer|March 31, 2015
Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC)Sepideh Saadatmand, Inge-Marie Obdeijn, Emiel J Rutgers, et al.
Breast Cancer Research and Treatment|September 21, 2017
Immunohistochemical versus molecular (BluePrint and MammaPrint) subtyping of breast carcinoma. Outcome results from the EORTC 10041/BIG 3-04 MINDACT trialG Viale, F A de Snoo, L Slaets, et al.
Journal of Biomedical Optics|September 8, 2011
Diagnosis of breast cancer using diffuse optical spectroscopy from 500 to 1600 nm: comparison of classification methodsRami Nachabé, Daniel J Evers, Benno H W Hendriks, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 20, 1998
European guidelines for quality assurance in the surgical management of mammographically detected lesionsN O'Higgins, D A Linos, M Blichert-Toft, et al.
Annales Chirurgiae Et Gynaecologiae|May 23, 1998
European guidelines for quality assurance in the surgical management of mammographically detected lesions. European Breast Cancer Working GroupN O'Higgins, D A Linos, M Blichert-Toft, et al.
Pageof 18

Showing results (151-160 of 179) with videos related to

Sort By:
Pageof 18
British Journal of Cancer|April 1, 1995
High-dose carboplatin, thiotepa and cyclophosphamide (CTC) with peripheral blood stem cell support in the adjuvant therapy of high-risk breast cancer: a practical approachE van der Wall, W J Nooijen, J W Baars, et al.
International Journal of Radiation Oncology, Biology, Physics|September 17, 2019
Response to Preoperative Radiation Therapy in Relation to Gene Expression Patterns in Breast Cancer PatientsSophie C J Bosma, Marlous Hoogstraat, Femke van der Leij, et al.
European Journal of Cancer (Oxford, England : 1990)|February 16, 2000
Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer. Dutch Study Group on local Recurrence after Breast Conservation (BORST)A C Voogd, J L Peterse, M A Crommelin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2018
Clinicopathological Risk Factors for an Invasive Breast Cancer Recurrence after Ductal Carcinoma <i>In Situ</i>-A Nested Case-Control StudyLindy L Visser, Lotte E Elshof, Michael Schaapveld, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|March 12, 2013
First clinical experience with a dedicated PET for hanging breast molecular imagingB B Koolen, T S Aukema, A J González Martínez, et al.
International Journal of Cancer|March 31, 2015
Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC)Sepideh Saadatmand, Inge-Marie Obdeijn, Emiel J Rutgers, et al.
Breast Cancer Research and Treatment|September 21, 2017
Immunohistochemical versus molecular (BluePrint and MammaPrint) subtyping of breast carcinoma. Outcome results from the EORTC 10041/BIG 3-04 MINDACT trialG Viale, F A de Snoo, L Slaets, et al.
Journal of Biomedical Optics|September 8, 2011
Diagnosis of breast cancer using diffuse optical spectroscopy from 500 to 1600 nm: comparison of classification methodsRami Nachabé, Daniel J Evers, Benno H W Hendriks, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 20, 1998
European guidelines for quality assurance in the surgical management of mammographically detected lesionsN O'Higgins, D A Linos, M Blichert-Toft, et al.
Annales Chirurgiae Et Gynaecologiae|May 23, 1998
European guidelines for quality assurance in the surgical management of mammographically detected lesions. European Breast Cancer Working GroupN O'Higgins, D A Linos, M Blichert-Toft, et al.
Pageof 18